DKA management from harrison

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
I now have all the key content from Harrison's 22E. Here is the complete DKA management summary:

DKA Management - Harrison's Principles of Internal Medicine, 22nd Edition (2025)


Classification of DKA Severity

SeveritypHSerum HCO3-Mental Status
Mild7.25-7.3015-18 meq/LNormal
Moderate7.0-7.2510-15 meq/LMildly reduced
Severe<7.0<10-15 meq/LReduced / Coma

Laboratory Values at Presentation (Table 416-7)

ParameterDKAHHS
Glucose11.1-33.3 mmol/L (250-600 mg/dL)33.3-66.6 mmol/L (600-1200 mg/dL)
Sodium125-135 meq/L135-145 meq/L
PotassiumNormal to ↑Normal
Serum β-hydroxybutyrate>3.0 mmol/L<1.0 mmol/L
Serum bicarbonate<18 meq/L>18 meq/L
Arterial pH6.8-7.3>7.3
Arterial PCO220-30 mmHgNormal
Osmolality>300 mOsm/mL>300 mOsm/mL
Serum/urine ketones+++/-
Euglycemic DKA (seen with SGLT2 inhibitor use): glucose 100-250 mg/dL, pH <7.3, ketones ++.

Management Protocol (Table 416-9)

1. Confirm Diagnosis

  • Elevated serum glucose
  • Elevated serum beta-hydroxybutyrate
  • Metabolic acidosis

2. Admission

  • ICU for severe DKA
  • Step-down unit with close monitoring for mild-moderate DKA

3. Initial Assessment

  • Serum electrolytes: K+, Na+, Mg2+, Cl-, HCO3-, phosphate
  • Acid-base status: pH, HCO3-, PCO2, beta-hydroxybutyrate
  • Renal function: creatinine, urine output

4. Fluid Replacement

Step 1 - Initial (first 1-3 hours):
  • 0.9% saline or Lactated Ringer's 2-3 L at 10-20 mL/kg/hour
  • Ringer's lactate is associated with more rapid DKA resolution and reduced risk of hyperchloremia compared to normal saline
Step 2 - After hemodynamic stabilization:
  • Switch to 0.45% saline at 250-500 mL/hour
Step 3 - When glucose reaches 250 mg/dL (13.9 mmol/L):
  • Change to 5-10% glucose + 0.45% saline or Ringer's lactate at 150-250 mL/hour
  • Total fluid deficit is typically 3-5 L, replaced over 24 hours
Euglycemic DKA: Start 5% or 10% dextrose infusion along with 0.9% saline from the start; adjust dextrose to prevent hypoglycemia.

5. Insulin

IV route (standard):
  • Bolus: 0.1 units/kg IV of short-acting regular insulin
  • Then 0.1 units/kg/hour continuous IV infusion
  • If no response in 2-4 hours, increase 2 to 3-fold
Subcutaneous route (mild-moderate DKA only):
  • 0.1 unit/kg rapid-acting insulin analogue SC, then 0.1 unit/kg every 1 hour
  • OR 0.2 unit/kg every 2 hours
Switching to SC insulin:
  • Do NOT discontinue IV insulin until 1-2 hours after the first SC insulin dose is given (to avoid rebound ketosis)
  • Continue IV insulin until glucose is <200 mg/dL AND the patient can eat

6. Potassium

  • Initial K+ is often normal or elevated (due to acidosis shifting K+ extracellularly), but total body potassium is depleted
  • If K+ <3.5 meq/L: Hold insulin; replace KCl at 40 meq/hour until K+ ≥3.5
  • If K+ 3.5-5.0 meq/L: Add 20-30 meq K+ per liter of IV fluid
  • If K+ >5.0 meq/L: Do not add potassium; monitor every 2 hours

7. Bicarbonate

  • Generally not recommended for most DKA patients
  • Consider if pH <7.0: 100 mmol NaHCO3 in 400 mL sterile water + 20 meq KCl over 2 hours
  • Risks: paradoxical CNS acidosis, worsening hypokalemia, delayed ketone clearance

8. Phosphate

  • Routine phosphate replacement is not recommended
  • Consider supplementation if serum phosphate <1.0 mg/dL, cardiac dysfunction, or respiratory depression

9. Monitoring

  • A comprehensive flow sheet is essential: vital signs, fluid intake/output, insulin administered, and lab values on a chronologic basis
  • Glucose should be checked every 1-2 hours
  • Electrolytes every 2-4 hours
  • Watch for signs of cerebral edema - most common in children, extremely serious

10. Identifying and Treating the Precipitant

Always look for and aggressively treat the precipitating cause:
  • Infection (most common) - look for signs even without fever
  • Missed/insufficient insulin doses
  • Physiologic stress (surgery, trauma, MI)
  • SGLT2 inhibitor use (euglycemic DKA)

11. Transition and Follow-up

  • After resolution, resume long-acting (basal) insulin before stopping IV insulin
  • Review the sequence of events that led to DKA - patient education is key
  • DKA can be recurrent, sometimes indicating underlying mental health issues, insulin cost barriers, or social determinants of health
  • Even a single episode of DKA is associated with greatly increased 1-year mortality

Clinical Pearls from Harrison's

  • Nausea/vomiting in a diabetic patient always warrants DKA workup
  • Abdominal pain can mimic acute pancreatitis or ruptured viscus
  • Kussmaul respirations + fruity breath = classic signs
  • Apparent normokalemia or hyperkalemia at presentation masks severe total body K+ depletion - K+ will fall rapidly with insulin
  • If the patient is vomiting or has altered mental status, insert a nasogastric tube to prevent aspiration
  • Failure to augment insulin during physiologic stress often precipitates DKA in established diabetics
  • Harrison's Principles of Internal Medicine, 22E (2025), Chapter 416, pp. 3260-3261
This is a shared conversation. Sign in to Orris to start your own chat.